A standard reverse-transcriptase polymerase chain reaction (PCR) methodology for detection of BCR-ABL1 transcripts [18] showed a single band that upon sequencing demonstrated an e19a2 BCRABL1 fusion leading to a diagnosis of chronic phase CML. This evidence concerns the gene ABL1 and chronic myelogenous leukemia, BCR-ABL1 positive.